The Hospital Research Foundation Group Impact Report - Flipbook - Page 27
CHILDHOOD CANCER
YOU are giving hope to our most vulnerable:
kids and young people with cancer.
Hope for leukaemia
Accessing proton therapy
Nothing could have prepared Catherine
Woulfe (left) for the devastating news that her
son Kilian (middle) had leukaemia.
More than 37 cancer patients have been able
to access proton therapy thanks to funding by
The Hospital Research Foundation Group for
a nationwide ‘comparative planning service’.
By the time the then 21-year-old was
diagnosed at Royal Perth Hospital, he was
unable to undergo regular chemotherapy.
So doctors and family opted for a targeted
treatment using Arsenic and Retinoic Acid –
an unconventional approach at the time, but
which ultimately saved his life.
That once-unconventional therapy is now
the first line of treatment thanks to years of
dedicated work by researchers like Dr Kim
Rice (right), thanks to your donations.
Proton therapy is yet to be established in
Australia, meaning patients still need to travel
overseas for this innovative treatment. To
apply for the Government’s overseas medical
support scheme, patients need a comparative
treatment plan to assess whether proton
therapy is the best option.
Thanks to you, cancer patients have been
able to access the comparative planning
service for free for the past 3.5 years.
Thank you for giving hope to families affected by cancer.
To save even more lives, please consider a donation via
(08) 8244 1100 or www.HospitalResearch.org.au
27
